Point mutations at the local anesthetic receptor site modulate the state-dependent block of rat Na v1.4 sodium channels by pyrazoline-type insecticides.
Pyrazoline-type insecticides (PTIs) selectively block sodium channels at membrane potentials that promote slow sodium channel inactivation and are proposed to interact with a site that overlaps the local anesthetic (LA) receptor site. Mutagenesis studies identified two amino acid residues in the S6 segment of homology domain IV (Phe-1579 and Tyr-1586 in the rat Na(v)1.4 sodium channel) as principal elements of the LA receptor. To test the hypothesis that PTIs bind to the LA receptor, we constructed mutated Na(v)1.4/F1579A and Na(v)1.4/Y1586A cDNAs, expressed native and mutated channels in Xenopus oocytes, and examined the effects of these mutations on channel block by three PTIs (indoxacarb, its bioactivation product DCJW, and RH3421) by two-electrode voltage clamp. DCJW and RH3421 had no effect on Na(v)1.4 channels held at -120mV but caused a slowly developing block upon depolarization to -30mV. Estimated IC(50) values following 15min of exposure were 1 and 4muM for DCJW and RH3421, respectively. Indoxacarb failed to block Na(v)1.4 channels under all experimental conditions. Sensitivity to block by DCJW and RH3421 at -30mV was significantly reduced in Na(v)1.4/F1579A channels, a finding that is consistent with the impact of this mutation on drug binding. In contrast to its effect on drug binding, the Y1586A mutation increased the sensitivity of Na(v)1.4 channels held at -30mV to all three compounds, conferring modest sensitivity to indoxacarb and increasing sensitivity to DCJW and RH3421 by 58- and 16-fold, respectively. These results provide direct evidence for the action of PTIs at the LA receptor.
Silver
Kristopher S
KS
Insecticide Toxicology Laboratory, Department of Entomology, New York State Agricultural Experiment Station, Cornell University, 630 W. North St., Geneva, NY 14456, USA.
Soderlund
David M
DM
D000779:Anesthetics, Local / Q000378:metabolism*; D000818:Animals; D018076:DNA, Complementary / Q000096:biosynthesis / Q000235:genetics; D003627:Data Interpretation, Statistical; D004594:Electrophysiology; D007306:Insecticides / Q000633:toxicity*; D015640:Ion Channel Gating / Q000187:drug effects; D009124:Muscle Proteins / Q000187:drug effects* / Q000235:genetics* / Q000378:metabolism; D009865:Oocytes / Q000187:drug effects / Q000378:metabolism; D010078:Oxazines / Q000494:pharmacology; D010671:Phenylurea Compounds / Q000494:pharmacology; D017354:Point Mutation / Q000502:physiology*; D011720:Pyrazoles / Q000494:pharmacology / Q000633:toxicity*; D051381:Rats; D011955:Receptors, Drug / Q000187:drug effects / Q000235:genetics*; D026941:Sodium Channel Blockers; D015222:Sodium Channels / Q000187:drug effects* / Q000235:genetics* / Q000378:metabolism; D014981:Xenopus
D000779:Anesthetics, Local; D018076:DNA, Complementary; D007306:Insecticides; D009124:Muscle Proteins; C510261:N-decarbomethoxyllated JW062; D010078:Oxazines; D010671:Phenylurea Compounds; D011720:Pyrazoles; D011955:Receptors, Drug; C466180:Scn4a protein, rat; D026941:Sodium Channel Blockers; D015222:Sodium Channels; C401104:indoxacarb; C072441:RH 3421